China delivers hope to rare disease patients
- Chris McMillan
- Mar 3
- 1 min read
China Daily
28th February 2025
China delivers hope to rare disease patients
When Ms. Liu, a cancer patient, picked up a box of medication at the hospital pharmacy, she felt an overwhelming sense of relief.
She had just become the first person in China to receive a prescription for Mitotane, the only drug approved for treating adrenocortical carcinoma -- a rare, aggressive cancer that affects the adrenal glands.
Just 48 hours after Mitotane was approved for marketing in the Chinese mainland on Jan. 7, the drug arrived at Peking Union Medical College Hospital (PUMCH), a national leader in rare disease diagnosis and treatment.
Comments